On Dec. 8, 2016, the New York State Department of Health announced several updates to its medical marijuana program, most notably the approval of medical marijuana wholesaling and lifting the cap on the number of available products for patients.
The state’s five licensed medical marijuana providers will now be allowed to wholesale their products to each other as a means of increasing the variety of products available at dispensaries. The state’s five providers have to submit proposals to the NYSDOH to participate in wholesaling. For the first time since the program launched, providers will also be allowed to offer more than five product types.
In addition to wholesaling and product expansion, the NYSDOH has approved hospitals to permit certified patients to self-administer medical marijuana and defined the recently added qualifying condition of chronic pain.
“These are major steps forward for New York’s Medical Marijuana Program and the thousands of patients who are benefiting from it every day,” said Dr. Howard A. Zucker, Commissioner of Health. “These enhancements will continue to strengthen the program and improve patient access by making medical marijuana available to patients suffering from chronic pain and making more products available at dispensing facilities across the state.”